Literature DB >> 34413950

Novel Heterocyclic Compounds as Delta-5-Desaturase Inhibitors for Treating Metabolic and Cardiovascular Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34413950      PMCID： PMC8366020          DOI： 10.1021/acsmedchemlett.1c00394

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  3 in total

Review 1.  Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases.

Authors:  Matthias B Schulze; Anne Marie Minihane; Rasha Noureldin M Saleh; Ulf Risérus
Journal:  Lancet Diabetes Endocrinol       Date:  2020-09-16       Impact factor: 32.069

Review 2.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

Review 3.  Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  Francesco Bellanti; Rosanna Villani; Antonio Facciorusso; Gianluigi Vendemiale; Gaetano Serviddio
Journal:  Free Radic Biol Med       Date:  2017-01-18       Impact factor: 7.376
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.